Brazil reports first research-targeted "embryo production" data
This article was originally published in Clinica
Executive Summary
Around 27,000 embryos were eligible for donation to Brazil's national stem cell research programme, according to the first annual embryo registration exercise, involving the country's 120 IVF clinics. By the first deadline (August 10), which sought to survey all embryos created until the end of 2007, some 50,000 were registered with the "national embryo production system" (SisEmbrio) by 50 clinics, said the Anvisa agency, which operates it. Anvisa thus estimates the total number of embryos to have been around 110,000. Only embryos that are unviable (genetically or morphologically defective) and supernumerary embryos stored for at least three years are eligible for research, subject to their being donated by the couple.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.